Key facts
- FeelBetter’s last known valuation is $11.7M (Jul 2023).
- It has raised $6.5M; the latest was Accelerator/Incubator in Apr 2026.
- Notable investors include Cliffbrake, ARC Innovation Center, Firstime, Good Company (Israel), Random Forest — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for FeelBetter
- ·The full record, as it builds
Funding rounds
No funding rounds for FeelBetter are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FeelBetter
Developer of an artificial intelligence-powered platform designed to improve medication management for patients with complex regimens. The company's platform uses machine learning and health data to identify individuals at risk of medication-related issues, recommend interventions, and integrate with healthcare workflows, enabling healthcare organizations and clinical pharmacists to reduce preventable hospitalizations and improve outcomes for older adults and those with chronic conditions.
- Sector
- Healthcare
- HQ
- Herzliya, Israel
- Founded
- 2018
- Employees
- 35
- Website
- feelbetter.healthcare/
- Ownership
- Privately Held (backing)
FeelBetter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FeelBetter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FeelBetter in its N-PORT filings yet. We sweep new filings monthly.